Independent Financial Group’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Independent Financial Group’s Portfolio SRNE Stock Details SRNE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-34,500	Closed	-$30.6K	–	891
2022 Q4	$30.6K	Sell	34,500 -12,500	-27%	-$16.6K	﹤0.01%	773
2022 Q3	$73.8K	Buy	47,000 +3,000	+7%	+$6.8K	0.01%	722
2022 Q2	$88.4K	Hold	44,000	–	–	0.01%	682
2022 Q1	$103K	Buy	44,000 +500	+1%	+$1.56K	0.01%	757
2021 Q4	$202K	Buy	43,500 +5,500	+14%	+$34.1K	0.02%	730
2021 Q3	$290K	Buy	38,000 +7,000	+23%	+$59.4K	0.03%	537
2021 Q2	$300K	Buy	31,000 +17,000	+121%	+$135K	0.03%	533
2021 Q1	$116K	Buy	14,000 +4,000	+40%	+$42.2K	0.02%	625
2020 Q4	$68.3K	Buy	+10,000	New	+$80.3K	0.01%	556

Other funds holding SRNE

Paloma Partners Greenwich, Connecticut $177M AUM 286.05% 1-Year Est. Return

Oaktree Capital Management Los Angeles, California $5.91B AUM 42.97% 1-Year Est. Return

Oaktree Fund Advisors Los Angles, California $56.9M AUM 80.32% 1-Year Est. Return

Crescent Grove Advisors Lake Forest, Illinois $1.01B AUM 17.78% 1-Year Est. Return

Lattice Capital Management Kirkland, Washington $56.9M AUM 49.15% 1-Year Est. Return

S&T Bank Indiana, Pennsylvania $268M AUM 39.92% 1-Year Est. Return

GoalVest Advisory New York $539M AUM 27.49% 1-Year Est. Return

Houlihan Financial Resource Group Ashburn, Virginia $257M AUM 14.19% 1-Year Est. Return

Valeo Financial Advisors Carmel, Indiana $4.74B AUM 27.69% 1-Year Est. Return

Granite Bay Wealth Management Portsmouth, New Hampshire $470M AUM 15.4% 1-Year Est. Return